(Q37866587)

English

Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis

scientific article published on August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

cerebrospinal fluid

0 references

Chlamydia pneumoniae

object named as

Chlamydia pneumoniae

1 reference

based on heuristic

inferred from title

Massimiliano Castellazzi

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

C Contini

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

R Cultrera

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

S Seraceni

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

E Granieri

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

E Fainardi

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

360-369

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Concepts of viral pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Pathogenesis of multiple sclerosis: an update on immunology

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Chlamydia pneumoniae infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Possible relationship of Chlamydia to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

'Touchdown' PCR to circumvent spurious priming during gene amplification

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1049OA

21 January 2018

Identifiers

10.1191/1352458504MS1049OA

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37866587&oldid=1795470055"